November 16, 2018

Avidea to present a plenary session at NeoAg Summit, Boston, MA

Improved induction of neoantigen-specific T cells with self-assembling nanoparticles


September 20, 2018

Avidea to speak at Bio+Tech18 Conference, Baltimore, MD

Cancer Immunotherapeutics session


May 23, 2018

Darrell Irvine, MIT Professor of Materials Science and Engineering, writes that Avidea’s technology linking TLR agonists to polymers is a “promising approach” to vaccine development in Nature Materials.

Material aid for vaccines


April 23, 2018

Avidea speaks at BioHealth Capital Region Forum 2018, Gaithersburg, MD

Universities:  From research to commercialization


April 15, 2018

Avidea collaborator presents a plenary session on the SNP-7/8a platform at AACR, Chicago, IL

Personalized therapies:  Neoantigen discovery and vaccination


April 11, 2018

Avidea collaborator presents on the SNP-7/8a platform at the Keystone Conference:  Myeloid Cells, Breckenridge, CO

Targeting Dendritic Cells and Monocytes with a Nanoparticle Neoantigen-TLR7/8 Agonist Vaccine Induces Anti-Tumor CD8 T Cell Immunity



January 20, 2018

Avidea collaborator presents on the SNP-7/8a platform at the Keystone Conference:  T Cell Dysfunction, Cancer and Infection, Breckenridge, CO

Adjuvants for T Cell Vaccines